Healthcare Market Research Reports & Industry Analysis

Healthcare refers to the field associated with maintaining or restoring patients’ health. These days’ Healthcare Industry falls into a lashing of discrete sub-sectors, and ancillary goods and services. Ranging from therapeutic equipment to medicinal drugs, medical tourism to sickness insurance, the Healthcare Market has been one of the most swiftly expanding sectors within the globe’s economic system.

Global Healthcare spending contributes close to 10% to the whole world’s GDP, though it varies noticeably with geography. Thus, the Western world’s average healthcare costs are far greater in contrast to those in the developing economies. North America alone is in charge of circa a half of the world’s overall spending on healthcare services. With budgets curtailments and growing costs, technology advances are increasingly taking a new meaning in the global Healthcare universe.

The research reports offer comprehensive insights into the market sizing, structure and dynamics of the Healthcare Industry based on various geographies, as well as in-depth market segmentation. The research reports incorporated in this Catalogue closely investigate the competition in the Healthcare Market, besides profiling countless market participants. Moreover, tomorrow's healthcare-related challenges are addressed, as well as projections into the future are provided in the research reports.

Publications found: 69,579

Sort by:

Isocitrate Dehydrogenase [NADP] Mitochondrial (NADP(+)-Specific ICDH or Oxalosuccinate Decarboxylase or ICD M or IDP or IDH2 or EC 1.1.1.42) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Isocitrate Dehydrogenase [NADP] Mitochondrial (NADP(+)-Specific ICDH or Oxalosuccinate Decarboxylase or ICD M or IDP or IDH2 or EC 1.1.1.42) Drugs in Development by Therapy Areas and Indications, Stag...

May 2022 39 pages

Janus Kinase (JAK or EC 2.7.10.2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 3,500.00

Janus Kinase (JAK or EC 2.7.10.2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Janus Kinase (JAK or EC 2.7.10.2) Drugs in Development...

May 2022 154 pages

Juvenile Rheumatoid Arthritis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Juvenile Rheumatoid Arthritis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Juvenile Rheumatoid Arthritis Drugs in Development by Stages, Target, MoA, RoA, Mo...

May 2022 38 pages

Kappa Type Opioid Receptor (KOR1 or OPRK or OPRK1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Kappa Type Opioid Receptor (KOR1 or OPRK or OPRK1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Kappa Type Opioid Receptor (KOR1 or OP...

May 2022 124 pages

Kelch Like ECH Associated Protein 1 (Cytosolic Inhibitor Of Nrf2 or Inrf2 or Kelch Like Protein 19 or KEAP1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Kelch Like ECH Associated Protein 1 (Cytosolic Inhibitor Of Nrf2 or Inrf2 or Kelch Like Protein 19 or KEAP1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and...

May 2022 35 pages

Kennedy’s Disease (Spinal and Bulbar Muscular Atrophy) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Kennedy’s Disease (Spinal and Bulbar Muscular Atrophy) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Kennedy’s Disease (Spinal and Bulbar Muscular Atrophy) Dr...

May 2022 38 pages

Keratoconjunctivitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Keratoconjunctivitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Keratoconjunctivitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Ke...

May 2022 198 pages

Ketohexokinase (Hepatic Fructokinase or KHK or EC 2.7.1.3) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Ketohexokinase (Hepatic Fructokinase or KHK or EC 2.7.1.3) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Ketohexokinase (Hepatic Fructo...

May 2022 36 pages

Klebsiella Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Klebsiella Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Klebsiella Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and...

May 2022 105 pages

Lafora Disease (Unverricht Disease) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Lafora Disease (Unverricht Disease) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Lafora Disease (Unverricht Disease) Drugs in Development by Stages, Target,...

May 2022 35 pages

Laminin-Deficient Congenital Muscular Dystrophy (LAMA2 MD or LAMA2-Related Muscular Dystrophy) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Laminin-Deficient Congenital Muscular Dystrophy (LAMA2 MD or LAMA2-Related Muscular Dystrophy) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Laminin-Deficient...

May 2022 35 pages

Large Conductance Mechanosensitive Channel (mscL) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Large Conductance Mechanosensitive Channel (mscL) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Large Conductance Mechanosensitive Chan...

May 2022 35 pages

Laryngeal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Laryngeal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Laryngeal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Player...

May 2022 84 pages

Lennox-Gastaut Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Lennox-Gastaut Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Lennox-Gastaut Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type...

May 2022 44 pages

Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Leptomeningeal Disease (Neoplastic...

May 2022 54 pages

Letterer-Siwe Disease (Multifocal and multisystemic (disseminated) Langerhans-cell histiocytosis) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Letterer-Siwe Disease (Multifocal and multisystemic (disseminated) Langerhans-cell histiocytosis) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Letterer-Siwe...

May 2022 38 pages

Leukocyte Immunoglobulin Like Receptor Subfamily B Member 2 (CD85 Antigen Like Family Member D or Immunoglobulin Like Transcript 4 or Monocyte-Macrophage Immunoglobulin Like Receptor 10 or CD85d or LILRB2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Leukocyte Immunoglobulin Like Receptor Subfamily B Member 2 (CD85 Antigen Like Family Member D or Immunoglobulin Like Transcript 4 or Monocyte-Macrophage Immunoglobulin Like Receptor 10 or CD85d or LI...

May 2022 43 pages

Leukotriene B4 (LTB4) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Leukotriene B4 (LTB4) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Leukotriene B4 (LTB4) Drugs in Development by Therapy Areas and Ind...

May 2022 36 pages

Lewy body Dementia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Lewy body Dementia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Lewy body Dementia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Pl...

May 2022 68 pages

Limb-Girdle Muscular Dystrophy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Limb-Girdle Muscular Dystrophy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Limb-Girdle Muscular Dystrophy Drugs in Development by Stages, Target, MoA, RoA,...

May 2022 52 pages

Lipase (EC 3.1.1.) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Lipase (EC 3.1.1.) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Lipase (EC 3.1.1.) Drugs in Development by Therapy Areas and Indicatio...

May 2022 87 pages

Lipid Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Lipid Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Lipid Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players...

May 2022 213 pages

Lipodystrophy (Lipoatrophy) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Lipodystrophy (Lipoatrophy) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Lipodystrophy (Lipoatrophy) Drugs in Development by Stages, Target, MoA, RoA, Molecu...

May 2022 40 pages

Lipopolysaccharide (Endotoxin) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Lipopolysaccharide (Endotoxin) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Lipopolysaccharide (Endotoxin) Drugs in Development by The...

May 2022 49 pages

Liposarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Liposarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Liposarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides...

May 2022 111 pages

Liver Fibrosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Liver Fibrosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Liver Fibrosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players pr...

May 2022 174 pages

Liver X Receptor (LXR) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Liver X Receptor (LXR) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Liver X Receptor (LXR) Drugs in Development by Therapy Areas and I...

May 2022 42 pages

Local Anesthetic Effect Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Local Anesthetic Effect Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Local Anesthetic Effect Drugs in Development by Stages, Target, MoA, RoA, Molecule Type...

May 2022 37 pages

Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b (CDw32 or Fc Gamma RII-b or CD32 or FCGR2B) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b (CDw32 or Fc Gamma RII-b or CD32 or FCGR2B) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Pla...

May 2022 42 pages

Low Density Lipoprotein Receptor Related Protein 6 (LRP6) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Low Density Lipoprotein Receptor Related Protein 6 (LRP6) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Low Density Lipoprotein Recepto...

May 2022 35 pages

Low-Grade Glioma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Low-Grade Glioma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Low-Grade Glioma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Player...

May 2022 55 pages

Lung Adenocarcinoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Lung Adenocarcinoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Lung Adenocarcinoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key...

May 2022 92 pages

Lung Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Lung Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Lung Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provid...

May 2022 80 pages

Lung Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Lung Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Lung Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players...

May 2022 48 pages

Lung Injury Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Lung Injury Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Lung Injury Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides...

May 2022 98 pages

Lupus Erythematosus Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Lupus Erythematosus Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Lupus Erythematosus Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key...

May 2022 290 pages

Lupus Nephritis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Lupus Nephritis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Lupus Nephritis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players...

May 2022 86 pages

Lymphoblastic Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Lymphoblastic Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Lymphoblastic Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type an...

May 2022 68 pages

Lymphocyte Activation Gene 3 Protein (Protein FDC or CD223 or LAG3) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Lymphocyte Activation Gene 3 Protein (Protein FDC or CD223 or LAG3) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Lymphocyte Activation...

May 2022 79 pages

Lymphoproliferative Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Lymphoproliferative Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Lymphoproliferative Disorders Drugs in Development by Stages, Target, MoA, RoA, Mo...

May 2022 52 pages

Lymphotoxin Alpha (TNF Beta or Tumor Necrosis Factor Ligand Superfamily Member 1 or LTA) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Lymphotoxin Alpha (TNF Beta or Tumor Necrosis Factor Ligand Superfamily Member 1 or LTA) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY...

May 2022 41 pages

Lysosomal Storage Disorder Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Lysosomal Storage Disorder Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Lysosomal Storage Disorder Drugs in Development by Stages, Target, MoA, RoA, Molecule...

May 2022 226 pages

Macrophage Stimulating Protein Receptor (CDw136 or Protein Tyrosine Kinase 8 or p185 Ron or CD136 or MST1R or EC 2.7.10.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Macrophage Stimulating Protein Receptor (CDw136 or Protein Tyrosine Kinase 8 or p185 Ron or CD136 or MST1R or EC 2.7.10.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Mole...

May 2022 36 pages

Major Depressive Disorder Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Major Depressive Disorder Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Major Depressive Disorder Drugs in Development by Stages, Target, MoA, RoA, Molecule T...

May 2022 153 pages

Major Prion Protein (ASCR or PrP27-30 or PrP33-35C or CD230 or PRNP) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Major Prion Protein (ASCR or PrP27-30 or PrP33-35C or CD230 or PRNP) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Major Prion Protein...

May 2022 35 pages

Male Sexual Dysfunction Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Male Sexual Dysfunction Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Male Sexual Dysfunction Drugs in Development by Stages, Target, MoA, RoA, Molecule Type...

May 2022 91 pages

Malignant Ascites Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Malignant Ascites Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Malignant Ascites Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Play...

May 2022 35 pages

Malignant Fibrous Histiocytoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Malignant Fibrous Histiocytoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Malignant Fibrous Histiocytoma Drugs in Development by Stages, Target, MoA, RoA,...

May 2022 52 pages

Malignant Glioma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Malignant Glioma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Malignant Glioma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Player...

May 2022 94 pages

Malignant Neoplasms Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Malignant Neoplasms Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Malignant Neoplasms Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key...

May 2022 52 pages

Filters

Clear all

Price

—

Date

—

Pages

—

Offers

33% OFF on “TCR-Based Antibody a...

Discount Offer from GMD Research

280

Special Offer from MP Advisors

Special Offer on Therapy Class R...